Wynnewood, PA (PRWEB) March 15, 2013
CD Diagnostics announced today that they will be featured in an upcoming episode of Health Heroes.
Located in Wynnewood, PA, CD Diagnostics is a leader in joint fluid analysis. The company’s scientific founder, Carl Deirmengian, MD, discovered the existence of unique genetic signatures for joint disease and infection, as indicated by the presence of various biomarkers in synovial (joint) fluid. By identifying and measuring these unique biomarkers, CD Diagnostics is able to develop a series of new products to diagnose joint disease with greater accuracy and speed than other tests currently available. The company’s first joint infection test, marketed as Synovasure™, was released as a laboratory developed test in November 2012 and continues to receive tremendous positive feedback from the orthopaedic community. A point of care device that will diagnose joint infection at the bedside is currently being developed, and the company plans to release this test in Europe later this year.
Matt Monaghan, Global Vice President of Zimmer Hips, commented that, "The early detection and treatment of infection is critical to successful clinical outcomes. We believe Synovasure™ will enable surgeons to quickly and accurately identify patients presenting with infection through a simple, streamlined process."
This particular episode of Health Heroes will educate our viewers about the impact of CD Diagnostics' game changing technology for the orthopaedic community. The company’s pipeline of tests will be the first simple, standardized, analytical devices available for joint fluid analysis. The Health Heroes feature will explain CD Diagnostics’ biomarker screening program, patented technology, and its core strengths in immunoassay development and manufacturing. Through the combination of its CLIA laboratory, Citrano Medical Laboratories, and its strength in immunoassay develo
Copyright©2012 Vocus, Inc.
All rights reserved